RedHill Biopharma Ltd. RDHL
Set alert
0.44 USD +0.05 +13.87%
At close
0.46 +0.02 +4.39%
Pre-market · Nov 3, 6:21 AM ET
0.39 Day range 0.4707
0.38 52-week range 1.60
- YTD
- -57.13%
- 1 year
- -66.03%
- Open
- 0.39
- Prev close
- 0.3878
- Mkt cap
- 3.92M
- Vol
- 313.54K
- Avg vol
- 2.07M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.39
- High
- 0.4707
- Forward P/E
- 210.67
- Beta
- 3.67
- Short ratio
- 0.37
- Inst. own
- 5.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 3, 2024
- 50-d avg
- 7.70
- 200-d avg
- 9.87
- 1y target
- 0.00
3M chart
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
Analyst view
Consensus: none
Price target (mean) 0.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -30.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -20.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |